信隆健康
(002105)
| 流通市值：14.25亿 | | | 总市值：14.40亿 |
| 流通股本：3.64亿 | | | 总股本：3.68亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 240,067,340.31 | 963,917,027.01 | 739,166,037.27 | 523,575,071.38 |
| 营业收入 | 240,067,340.31 | 963,917,027.01 | 739,166,037.27 | 523,575,071.38 |
| 二、营业总成本 | 235,752,167.46 | 965,435,220.28 | 731,155,214.55 | 497,518,228.94 |
| 营业成本 | 198,945,245.87 | 785,139,204.69 | 604,693,798.29 | 417,417,691.41 |
| 税金及附加 | 1,877,560.53 | 10,304,738.53 | 7,400,852.27 | 6,119,499.18 |
| 销售费用 | 6,273,454.66 | 28,875,732.71 | 22,205,040.15 | 15,189,891.67 |
| 管理费用 | 19,994,291.28 | 91,029,644.27 | 62,979,912.81 | 41,965,036.84 |
| 研发费用 | 9,820,715.71 | 45,583,241 | 34,001,446.87 | 20,878,806.68 |
| 财务费用 | -1,159,100.59 | 4,502,659.08 | -125,835.84 | -4,052,696.84 |
| 其中:利息费用 | 3,081,296.04 | 16,888,789.59 | 12,898,819.06 | 8,460,895.04 |
| 其中:利息收入 | 2,113,584.32 | 8,324,411.78 | 5,670,808.48 | 3,392,965.4 |
| 加:公允价值变动收益 | - | - | - | -13,580 |
| 加:投资收益 | -1,181,183.53 | -627,491.49 | 674,752.93 | -1,378,790.21 |
| 资产处置收益 | -236,011.88 | -87,807.9 | 42,485.29 | 39,816.05 |
| 资产减值损失(新) | - | -5,990,836.97 | -231,184.41 | -1,873,411.92 |
| 信用减值损失(新) | 530,355.05 | -498,160.18 | 1,247,379.65 | 3,203,904.55 |
| 其他收益 | 401,622.27 | 1,597,601.57 | 3,460,749.02 | 2,753,580.68 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 3,829,954.76 | -7,124,888.24 | 13,205,005.2 | 28,788,361.59 |
| 加:营业外收入 | 394,624.77 | 24,151,271.33 | 13,580,782.93 | 8,961,067.01 |
| 减:营业外支出 | 579,559.96 | 3,048,162.97 | 2,574,601.88 | 1,366,504.4 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 3,645,019.57 | 13,978,220.12 | 24,211,186.25 | 36,382,924.2 |
| 减:所得税费用 | 925,045.5 | -2,854,965.35 | 5,553,039.16 | 6,441,433.85 |
| 六、净利润 | 2,719,974.07 | 16,833,185.47 | 18,658,147.09 | 29,941,490.35 |
| 持续经营净利润 | 2,719,974.07 | 16,833,185.47 | 18,658,147.09 | 29,941,490.35 |
| 归属于母公司股东的净利润 | 2,457,102.84 | 21,702,672.34 | 22,132,285.23 | 31,177,055.28 |
| 少数股东损益 | 262,871.23 | -4,869,486.87 | -3,474,138.14 | -1,235,564.93 |
| (一)基本每股收益 | 0.01 | 0.06 | 0.06 | 0.09 |
| (二)稀释每股收益 | 0.01 | 0.06 | 0.06 | 0.09 |
| 八、其他综合收益 | 64,352.72 | -6,381,731.94 | -7,217,230.07 | 4,211,121.08 |
| 归属于母公司股东的其他综合收益 | 32,858.37 | -3,507,451.51 | -4,878,397.09 | 1,662,001.5 |
| 九、综合收益总额 | 2,784,326.79 | 10,451,453.53 | 11,440,917.02 | 34,152,611.43 |
| 归属于母公司股东的综合收益总额 | 2,489,961.21 | 18,195,220.83 | 17,253,888.14 | 32,839,056.78 |
| 归属于少数股东的综合收益总额 | 294,365.58 | -7,743,767.3 | -5,812,971.12 | 1,313,554.65 |
| 公告日期 | 2024-04-27 | 2024-04-24 | 2023-10-28 | 2023-08-26 |
| 审计意见(境内) | | 标准无保留意见 | | |